To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Antibiotic resistance flourishes in freshwater systems
Researchers discover resistance in freshwater systems throughout Ontario
27-04-2012
The author Dr. Seuss may have been on to something when he imagined that microscopic communities could live and flourish on small specs of dust, barely visible to the naked eye. In fact, such vibrant communities exist – in a material with a Seussical sounding, yet scientific name called ...
Darwin in the genome
Research on stickleback fish shows how adaptation to new environments involves many genes
04-04-2012
A current controversy raging in evolutionary biology is whether adaptation to new environments is the result of many genes, each of relatively small effect, or just a few genes of large effect. A new study published in Molecular Ecology strongly supports the first "many-small" ...
Scientists clone 'survivor' elm trees
03-04-2012
Scientists at the University of Guelph have found a way to successfully clone American elm trees that have survived repeated epidemics of their biggest killer — Dutch elm disease.The breakthrough, published in the Canadian Journal of Forest Research, is the first known use of in vitro culture ...
Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs
30-03-2012
Allon Therapeutics Inc. announced that it has been granted a U.S. patent that covers the use of the Company’s neuroprotective technology platform in the treatment of peripheral neuropathy. This includes the Company’s lead drug candidate, davunetide, and pipeline product AL-309 as treatments ...
Genetic regulators hijacked by avian and swine flu viruses identified: UBC study
30-03-2012
Researchers at the University of British Columbia have identified a number of tiny but powerful "genetic regulators" that are hijacked by avian and swine flu viruses during human infection.The discovery, published in the Journal of Virology, could reveal new targets for broad-spectrum ...
Allon advances Parkinson’s disease program
14-03-2012
Allon Therapeutics Inc. announced the completion of its first phase of work in a preclinical Parkinson’s disease (PD) model and advancement into the second phase of work. Both phases are funded by The Michael J. Fox Foundation (MJFF) for Parkinson’s Research and carried out by Prof. ...
Allon broadens intellectual property with new patent
07-03-2012
Allon Therapeutics Inc. announced that it has been granted a patent relating to the use of Allon’s drug candidates, including lead drug candidate davunetide and pipeline product AL-309, to treat certain types of peripheral neurotoxicity. This new Australian patent strengthens Allon’s ...
Amorfix appoints Lynda Covello Vice President of Strategic Alliances
28-02-2012
Amorfix Life Sciences announced the Company has appointed Lynda Covello as Vice President of Strategic Alliances. Ms. Covello is a seasoned executive with more than 20 years experience in the biotech and biopharma sector where she has acted as consultant, counsel and senior executive. She ...
Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
08-02-2012
Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc.. This action was required ...
IRCM researchers fuel an important debate in the field of molecular biology
30-01-2012
Dr. François Robert, molecular biology researcher at the Institut de recherches cliniques de Montréal (IRCM), and his team confirmed that the phosphorylation of RNA polymerase II, a key enzyme in the process of gene expression, is uniform across all genes. This discovery, which contributes to ...
Netmeeting
